Clinical Trials Directory

Trials / Completed

CompletedNCT05426902

Utilizing Qualitative and Quantitative Methods to Understand a New Model of Type 1 and 2 Systemic Lupus Erythematosus (SLE)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
16 (actual)
Sponsor
Duke University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to pilot test SLE@Duke, a set of tools to implement the Type 1 \& 2 SLE Model in a clinical setting, as well as to gain an in-depth understanding of providers experiences using the intervention during clinic visits with patients with systemic lupus erythematosus. This record represents Aim 3 of this study.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSLE@DukeSLE@Duke is a set of tools to implement the Type 1 \& 2 SLE Model in a clinical setting. The model includes an Electronic Medical Record (EMR) note template, patient-reported outcome measure, and training on how to discuss Type 1 \& 2 SLE.

Timeline

Start date
2022-01-03
Primary completion
2022-06-30
Completion
2022-06-30
First posted
2022-06-22
Last updated
2023-09-14
Results posted
2023-09-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05426902. Inclusion in this directory is not an endorsement.